TP53 and lung carcinoma: Human lung cancer cells harboring wt-TP53 have higher DOC sensitivity than cells harboring abnormal TP53. Whereas, human lung cancer cells harboring abnormal TP53 have higher lovastatin sensitivity than cells harboring wt-TP53.